| Dr Michael I Lewis, MD | |
|
8700 Beverly Blvd., Los Angeles, CA 90048-1865 | |
| (310) 423-1837 | |
| (310) 423-0129 |
| Full Name | Dr Michael I Lewis |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 50 Years |
| Location | 8700 Beverly Blvd., Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801824941 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A42166 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cedars-sinai Medical Center | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cedars-sinai Medical Center Pharmacy 3 | 0446169114 | 648 |
| Cedars-sinai Medical Care Foundation | 0941106645 | 1116 |
News Archive
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
University of Alabama at Birmingham researchers have found a previously unknown step in the pathway that leads to asthma, a discovery that may offer new therapeutic approaches to this incurable disease. Asthma affects more than 25 million people in the United States, including about 7 million children.
New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.
USA Today reports on "how other developed countries provide and pay for health care compared with the U.S. system, based on the most recent information available." For example, they report that "Germany requires people making less than about $70,000 a year to have health insurance, which is operated by more than 200 competing, non-profit insurance companies."
› Verified 5 days ago
| Entity Name | Cedars-sinai Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316984388 PECOS PAC ID: 0941106645 Enrollment ID: O20040202000464 |
News Archive
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
University of Alabama at Birmingham researchers have found a previously unknown step in the pathway that leads to asthma, a discovery that may offer new therapeutic approaches to this incurable disease. Asthma affects more than 25 million people in the United States, including about 7 million children.
New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.
USA Today reports on "how other developed countries provide and pay for health care compared with the U.S. system, based on the most recent information available." For example, they report that "Germany requires people making less than about $70,000 a year to have health insurance, which is operated by more than 200 competing, non-profit insurance companies."
› Verified 5 days ago
| Entity Name | Cedars-sinai Medical Center Pharmacy #3 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639172372 PECOS PAC ID: 0446169114 Enrollment ID: O20040204000886 |
News Archive
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
University of Alabama at Birmingham researchers have found a previously unknown step in the pathway that leads to asthma, a discovery that may offer new therapeutic approaches to this incurable disease. Asthma affects more than 25 million people in the United States, including about 7 million children.
New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.
USA Today reports on "how other developed countries provide and pay for health care compared with the U.S. system, based on the most recent information available." For example, they report that "Germany requires people making less than about $70,000 a year to have health insurance, which is operated by more than 200 competing, non-profit insurance companies."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael I Lewis, MD Po Box 512717, Los Angeles, CA 90051-0717 Ph: (310) 423-1837 | Dr Michael I Lewis, MD 8700 Beverly Blvd., Los Angeles, CA 90048-1865 Ph: (310) 423-1837 |
News Archive
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
University of Alabama at Birmingham researchers have found a previously unknown step in the pathway that leads to asthma, a discovery that may offer new therapeutic approaches to this incurable disease. Asthma affects more than 25 million people in the United States, including about 7 million children.
New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.
USA Today reports on "how other developed countries provide and pay for health care compared with the U.S. system, based on the most recent information available." For example, they report that "Germany requires people making less than about $70,000 a year to have health insurance, which is operated by more than 200 competing, non-profit insurance companies."
› Verified 5 days ago
Dr. Linda Fong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-3290 | |
Dr. Robert Peter Gale, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049 Phone: 310-442-9010 | |
Dr. Tarek Alasil, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045 Phone: 310-673-2020 Fax: 310-469-5290 | |
David Michael Tellalian, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048 Phone: 310-358-2300 Fax: 310-358-2308 | |
Dr. Jan B King, M.D., M.P.H. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059 Phone: 323-568-8701 | |
Dr. Caroline Hwang, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033 Phone: 323-442-5100 | |
Dr. Jennifer A Fulcher, M.D., PH.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095 Phone: 310-825-7225 |